ENTA vs. QVCGA
ENTA (Enanta Pharmaceuticals, Inc.) and QVCGA (QVC Group Inc) are both stocks. ENTA operates in Biotechnology (Healthcare), while QVCGA operates in Internet Retail (Consumer Cyclical).
Performance
ENTA vs. QVCGA - Performance Comparison
Loading charts...
Returns By Period
ENTA
- 1D
- -1.86%
- 1M
- -27.84%
- YTD
- -29.80%
- 6M
- -21.93%
- 1Y
- 48.19%
- 3Y*
- -24.76%
- 5Y*
- -25.36%
- 10Y*
- -7.18%
QVCGA
- 1D
- 0.00%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ENTA vs. QVCGA - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
ENTA Enanta Pharmaceuticals, Inc. | -16.33% |
QVCGA QVC Group Inc | 0.00% |
Fundamentals
ENTA:
$319.83M
QVCGA:
$2.75M
ENTA:
-$2.67
QVCGA:
-$302.09
ENTA:
3.72
QVCGA:
0.00
ENTA:
$69.21M
QVCGA:
$9.23B
ENTA:
$33.44M
QVCGA:
$2.89B
ENTA:
-$61.85M
QVCGA:
$789.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENTA vs. QVCGA — Risk / Return Rank
ENTA
QVCGA
ENTA vs. QVCGA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enanta Pharmaceuticals, Inc. (ENTA) and QVC Group Inc (QVCGA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ENTA | QVCGA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.24 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.41 | — | — |
| Martin ratioReturn relative to average drawdown | 2.72 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ENTA | QVCGA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.44 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.12 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.05 | — | — |
Drawdowns
ENTA vs. QVCGA - Drawdown Comparison
The maximum ENTA drawdown since its inception was -96.63%, which is greater than QVCGA's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for ENTA and QVCGA.
Loading charts...
Drawdown Indicators
| ENTA | QVCGA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.63% | 0.00% | -96.63% |
Max Drawdown (1Y)Largest decline over 1 year | -34.30% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -83.61% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -95.62% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -96.63% | — | — |
Current DrawdownCurrent decline from peak | -91.24% | 0.00% | -91.24% |
Average DrawdownAverage peak-to-trough decline | -49.23% | 0.00% | -49.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.76% | — | — |
Volatility
ENTA vs. QVCGA - Volatility Comparison
Loading charts...
Volatility by Period
| ENTA | QVCGA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.36% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 35.53% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 109.93% | 0.00% | +109.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 73.36% | 0.00% | +73.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.70% | 0.00% | +60.70% |
Dividends
ENTA vs. QVCGA - Dividend Comparison
Neither ENTA nor QVCGA has paid dividends to shareholders.
Financials
ENTA vs. QVCGA - Financials Comparison
This section allows you to compare key financial metrics between Enanta Pharmaceuticals, Inc. and QVC Group Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Find the right allocation for ENTA and QVCGA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer